[go: up one dir, main page]

AR024122A1 - Metodo para la estabilizacion intensificada de proteinas y produccion de lineas celulares que sirven para la produccion de dichas proteinas estabilizadas - Google Patents

Metodo para la estabilizacion intensificada de proteinas y produccion de lineas celulares que sirven para la produccion de dichas proteinas estabilizadas

Info

Publication number
AR024122A1
AR024122A1 ARP000102591A ARP000102591A AR024122A1 AR 024122 A1 AR024122 A1 AR 024122A1 AR P000102591 A ARP000102591 A AR P000102591A AR P000102591 A ARP000102591 A AR P000102591A AR 024122 A1 AR024122 A1 AR 024122A1
Authority
AR
Argentina
Prior art keywords
production
proteins
stabilization
intensified
methods
Prior art date
Application number
ARP000102591A
Other languages
English (en)
Original Assignee
Photogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photogen Inc filed Critical Photogen Inc
Publication of AR024122A1 publication Critical patent/AR024122A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18451—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un método para aumentar el rendimiento de la produccion de virus, proteínas virales y demás materiales biologicos relacionados por medio del control yestabilizacion intensificados de la produccion de proteínas por medio de proteínas de stress y los productos proteicos resultantes. La presente también serefiere a métodos para la seleccion o manipulacion de líneas celulares que den origen a dichos productos con estabilizacion intensificada. Más específicamente,las realizaciones ejemplificadas de la presente se refieren a métodos para intensificar la produccion de un agente viral, la produccion de líneas celulares queexhiban modificacion genética permanente, la produccion de líneas celulares eucarioticas permisivas, el aumento del rendimientodel producto recombinantefuncional, así como a los productos de dichos métodos.
ARP000102591A 1999-05-28 2000-05-26 Metodo para la estabilizacion intensificada de proteinas y produccion de lineas celulares que sirven para la produccion de dichas proteinas estabilizadas AR024122A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13667699P 1999-05-28 1999-05-28
US09/543,479 US6495360B1 (en) 1999-05-28 2000-04-06 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins

Publications (1)

Publication Number Publication Date
AR024122A1 true AR024122A1 (es) 2002-09-04

Family

ID=26834532

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102591A AR024122A1 (es) 1999-05-28 2000-05-26 Metodo para la estabilizacion intensificada de proteinas y produccion de lineas celulares que sirven para la produccion de dichas proteinas estabilizadas

Country Status (12)

Country Link
US (4) US6495360B1 (es)
EP (1) EP1187841A4 (es)
JP (1) JP2003501014A (es)
KR (1) KR20020028884A (es)
CN (1) CN1359388A (es)
AR (1) AR024122A1 (es)
AU (1) AU4857000A (es)
BR (1) BR0011046A (es)
CA (1) CA2372243A1 (es)
IL (1) IL146711A0 (es)
MX (1) MXPA01012216A (es)
WO (1) WO2000073319A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10121235A1 (de) * 2001-04-30 2002-10-31 Roche Diagnostics Gmbh Verfahren zur Expression von Proteinen in in vitro Translations-Systemen unter Ko-Expression von Faltungshelferproteinen
US7244616B2 (en) 2003-06-27 2007-07-17 Bayer Pharmaceuticals Corporation Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
EP2199385A1 (en) 2008-12-16 2010-06-23 ProBioGen AG Specific and persistent activation of heat shock response in cell lines using a viral factor
US20130280269A1 (en) * 2010-06-08 2013-10-24 National University Of Ireland Manipulation of HSP70 and IRE1Alpha Protein Interactions
GB201104897D0 (en) 2011-03-23 2011-05-04 Immunobiology Ltd Method for the production of protein complexes and vaccine compositions comprising the same
EP2845904A1 (en) * 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
CN107841514A (zh) * 2017-12-15 2018-03-27 浙江省萧山棉麻研究所 一种提高印度梨形孢液体发酵产物产量的方法
WO2022191253A1 (ja) * 2021-03-10 2022-09-15 住友ファーマ株式会社 融合タンパク質の製造方法
CN116981778A (zh) * 2021-03-10 2023-10-31 住友制药株式会社 半胱氨酸结蛋白的制造方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1596653A (en) * 1977-01-26 1981-08-26 Gist Brocades Nv Vaccine
US4211843A (en) * 1977-11-30 1980-07-08 L'institut Armand-Frappier Strain of measles virus and process of producing the same
US4303645A (en) * 1980-04-18 1981-12-01 Cornell Research Foundation, Inc. Modified living canine parvovirus vaccine
US4957737A (en) * 1986-05-27 1990-09-18 Hoffmann-La Roche Inc. HTLV-III (LAV) envelope peptides
DE3926103A1 (de) 1989-08-08 1991-02-14 Hoechst Ag Verfahren zur biokatalytischen korrekten kettenfaltung denaturierter rekombinanter fusionsproteine
DE69027526T3 (de) * 1989-11-06 2005-03-24 Cell Genesys, Inc., Foster City Herstellung von proteinen mittels homologer rekombination
US5348945A (en) 1990-04-06 1994-09-20 Wake Forest University Method of treatment with hsp70
US5188964A (en) 1990-04-12 1993-02-23 Board Of Regents, The University Of Texas System Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
EP0573429A1 (en) 1990-10-26 1993-12-15 MCALPINE, Peter, Michael Spinnaker pole control system and spinnaker pole end thereof
DE4201181A1 (de) 1992-01-17 1993-07-22 Boehringer Mannheim Gmbh Verfahren zur stabilisierung von proteinen
JPH07505719A (ja) 1992-04-14 1995-06-22 デューク・ユニバーシティー ｐ５３及びＨＳＰ７０のコンプレックスを含む腫瘍の検出方法
DE69329202T2 (de) * 1992-10-02 2001-03-29 Research Corp. Technologies, Inc. Methoden der erhöhung der sekretion von überexpremierten proteinen
GB9223816D0 (en) * 1992-11-13 1993-01-06 Medical Res Council Heat shock proteins and the treatment of tumours
US5674703A (en) * 1992-12-02 1997-10-07 Woo; Savio L. C. Episomal vector systems and related methods
US5750119A (en) 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
US5872005A (en) * 1994-11-03 1999-02-16 Cell Genesys Inc. Packaging cell lines for adeno-associated viral vectors
JP3656277B2 (ja) * 1995-05-17 2005-06-08 味の素株式会社 組換えｄｎａ法によるトランスグルタミナーゼの効率的製造法
US5837251A (en) 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
US5739018A (en) * 1996-08-07 1998-04-14 The Regents Of The University Of California Packaging cell lines for pseudotyped retroviral vectors
US5830464A (en) 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
JP3344618B2 (ja) * 1997-06-20 2002-11-11 株式会社エイチ・エス・ピー研究所 シャペロン発現プラスミド
AU1275299A (en) * 1997-10-23 1999-05-10 Uab Research Foundation Human papillomavirus vectors for the episomal transduction of host cells and method of making same
EP2295065B1 (en) * 1998-02-20 2013-10-09 The University of Miami Modified heat shock protein-antigenic peptide complex
EP1090108B1 (en) * 1998-06-03 2011-02-23 Wyeth Holdings Corporation Novel methods for rescue of rna viruses

Also Published As

Publication number Publication date
US6495360B1 (en) 2002-12-17
US6541223B2 (en) 2003-04-01
JP2003501014A (ja) 2003-01-14
US20010041361A1 (en) 2001-11-15
CA2372243A1 (en) 2000-12-07
US20010044146A1 (en) 2001-11-22
AU4857000A (en) 2000-12-18
EP1187841A1 (en) 2002-03-20
WO2000073319A1 (en) 2000-12-07
US6468777B2 (en) 2002-10-22
CN1359388A (zh) 2002-07-17
KR20020028884A (ko) 2002-04-17
MXPA01012216A (es) 2002-07-02
EP1187841A4 (en) 2004-12-08
IL146711A0 (en) 2002-07-25
BR0011046A (pt) 2002-04-16
US20010041354A1 (en) 2001-11-15
US6451597B2 (en) 2002-09-17

Similar Documents

Publication Publication Date Title
PL1685243T3 (pl) Unieśmiertelnione ptasie linie komórkowe do wytwarzania wirusów
CL2021002739A1 (es) Proteína crispr de prevotella y francisella 1 (cpf1) aislada de acidaminococcus sp. bv3l6; proteína de fusión que la comprende; ácido nucleico; vector; métodos para alterar el genoma de una célula o una molécula de adn bicatenario in vitro que utilizan dichas proteínas (divisional de sol. 201903004)
WO2020198509A3 (en) Modified oligonucleotides with increased stability
EA200200960A1 (ru) Промоторы вируса желтого скручивания листьев цестровых
CY1110716T1 (el) Πολλαπλασιασμος ιων εντος κυτταροκαλλιεργειας
DE69535940D1 (de) Verfahren zur Herstellung von biologischen Produkten in Protein-freiem Kultur
MY151062A (en) Pseudoinfectious flavivirus and uses thereof
DE60236182D1 (de) Zufällige integration von polynukleotide nach in vivo linearisierung
ATE270342T1 (de) Endosomolytisch wirksame partikel
CY1114598T1 (el) Μεθοδος για την ενισχυση ενος ιου φυσαλιδωδους νοσου υπο συνθηκες ελευθερες ορου
AR024122A1 (es) Metodo para la estabilizacion intensificada de proteinas y produccion de lineas celulares que sirven para la produccion de dichas proteinas estabilizadas
MX387420B (es) Producción de virus en cultivos celulares.
ES2078971T3 (es) Produccion de virus y purificacion de proteinas con envoltura virica para uso en vacunas.
ATE365807T1 (de) Hepatitis b virus vektoren für gentherapie
EP4410970A3 (en) Efficient cell culture system for hepatitis c virus genotype 6a
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
BR0008187A (pt) Controle biológico de nematódeos
DE60042922D1 (de) Virale expressionsvektoren für pflanzen
PE20001331A1 (es) Identificacion de genotipos senv
AR024212A1 (es) Virus celo recombinante y adn de virus celo.
WO2002083896A3 (en) Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
ATE294565T1 (de) Verwendung von alkoxylierten ungesättigten fettsäuren als antitranspirantien
WO2007002512A3 (en) Neuroprotective effective compound
ATE459643T1 (de) Ee3-proteinfamilie und zugrundeliegende dna- sequenzen
WO2006023956A3 (en) Method for gene transfer into the organelles of cells: direct gene transfer to mitochondria